Literature DB >> 6086752

Activated T cells in vivo and in vitro: divergence in expression of Tac and Ia antigens in the nonblastoid small T cells of inflammation and normal T cells activated in vitro.

G R Burmester, B Jahn, M Gramatzki, J Zacher, J R Kalden.   

Abstract

Elevated numbers of non-blastoid T cells expressing either the Tac or Ia antigens were found on separate cell populations in inflammatory synovial tissues and fluids of individuals with arthritis. Those synovial T cell preparations containing Tac+ cells exhibited marked proliferation upon the addition of IL 2 without concomitant mitogen stimulation; T cell eluates containing Ia+ but not Tac+ T cells did not show significantly increased levels of blastogenesis. Paired T cell preparations from blood had only minor increases in the number of Tac+ T cells and moderate increases in the number of Ia+ cells. The blood cells did not exhibit significant proliferation to IL 2. In contrast mitogen or allogeneic activation of T cells induced blastoid cells that expressed abundant per cell amount of Ia or Tac antigens. These blastoid cells resembled the small T cells of inflammation in having only very limited overlap between the population that bore Ia antigens and those with the Tac antigen; however, there was a preponderance of Tac-bearing cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6086752

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  47 in total

1.  Evidence for the presence of activated CD4 T cells with naive phenotype in the peripheral blood of patients with rheumatoid arthritis.

Authors:  D Maurer; T Felzmann; W Holter; P Petera; J Smolen; W Knapp
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

2.  Inflammation of the subacromial bursa in chronic shoulder pain.

Authors:  S Santavirta; Y T Konttinen; I Antti-Poika; D Nordström
Journal:  Arch Orthop Trauma Surg       Date:  1992       Impact factor: 3.067

Review 3.  Possibilities for the immunotherapy of rheumatoid arthritis.

Authors:  F C Breedveld; R R De Vries
Journal:  Clin Rheumatol       Date:  1990-06       Impact factor: 2.980

Review 4.  Immunotherapy through the IL-2 receptor.

Authors:  H A Verheul; M Verveld; E S Bos
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

5.  Stimulation of rheumatoid synovial and blood T cells and lines by synovial fluid and interleukin-2: characterization of clones and recognition of a co-stimulatory effect.

Authors:  N Hain; S Alsalameh; W M Bertling; J R Kalden; G R Burmester
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

6.  Basis for defective responses of rheumatoid arthritis synovial fluid lymphocytes to anti-CD3 (T3) antibodies.

Authors:  M Lotz; C D Tsoukas; C A Robinson; C A Dinarello; D A Carson; J H Vaughan
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

7.  Interleukin 2 inhibitor in synovial fluid.

Authors:  P Emery; K C Gentry; A Kelso; I R Mackay
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

8.  Spontaneous recovery of the decreased expression in vitro of interleukin 2 receptors in rheumatoid arthritis.

Authors:  C Plater-Zyberk; K A Rockett; R N Maini
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

9.  Heterogeneity of T cell receptor idiotypes in rheumatoid arthritis.

Authors:  F M Brennan; S Allard; M Londei; C Savill; A Boylston; S Carrel; R N Maini; M Feldmann
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

10.  Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1 beta production by synovial T cells.

Authors:  E Robinson; E C Keystone; T J Schall; N Gillett; E N Fish
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.